Evidence map›Paper›PMID 22630155›Full record

ReviewNanomedicine (London, England)2012

Molecular plasmonics for biology and nanomedicine.

Yue Bing Zheng, Brian Kiraly, Paul S Weiss, Tony Jun Huang

Abstract readReview
In one paragraph

Review in Nanomedicine (London, England), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Direct Bottom-UpChemical reviews · 2023
    Review
  3. Article
  4. Near-infrared fluorescence imaging in immunotherapy.Advanced drug delivery reviews · 2020
    Review
  5. Nanoscopy through a plasmonic nanolens.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Plasmofluidics: Merging Light and Fluids at the Micro-/Nanoscale.Small (Weinheim an der Bergstrasse, Germany) · 2015
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yue Bing ZhengCalifornia NanoSystems Institute, University of California, Los Angeles, CA 90095, USA.
Brian Kiraly
Paul S Weiss
Tony Jun Huang

Funding

On-Chip Optofluidic Laser Scanning Confocal Microscope for Early Cancer DetectionDP2OD007209 · OD · PENNSYLVANIA STATE UNIVERSITY, THE · PI HUANG, TONY JUN · 2010 to 2010
$2.2M
NIH HHS 1DP2OD007209-01NIH HHS DP2 OD007209
6 · The paper itself

Abstract

The optical excitation of surface plasmons in metal nanoparticles leads to nanoscale spatial confinement of electromagnetic fields. The confined electromagnetic fields can generate intense, localized thermal energy and large near-field optical forces. The interaction between these effects and nearby molecules has led to the emerging field known as molecular plasmonics. Recent advances in molecular plasmonics have enabled novel optical materials and devices with applications in biology and nanomedicine. In this article, we categorize three main types of interactions between molecules and surface plasmons: optical, thermal and mechanical. Within the scope of each type of interaction, we will review applications of molecular plasmonics in biology and nanomedicine. We include a wide range of applications that involve sensing, spectral analysis, imaging, delivery, manipulation and heating of molecules, biomolecules or cells using plasmonic effects. We also briefly describe the physical principles of molecular plasmonics and progress in the nanofabrication, surface functionalization and bioconjugation of metal nanoparticles.

Indexed as

Drug Delivery SystemsMetal NanoparticlesSurface Plasmon ResonanceAnimalsBiosensing TechniquesHumansMolecular ImagingNanomedicineSpectrum Analysis, Raman

Identifiers

PMID22630155
PMCPMC3991779

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.